Peter L. Salgo, MD: How do the biologics impact the asthma inflammatory pathway, and what is the targeted pathway for the treatment of asthma in the first place? Linda S. Cox, MD, FAAAAI, FACAAI, FACP ...

Study results suggest immune checkpoint inhibitor therapy may offer immunomodulatory benefits for patients with asthma and ...

Please provide your email address to receive an email when new articles are posted on . The effect of electronic cigarettes without nicotine on allergic airway disease may depend on flavor, which ...

The authors write that once severe asthma is diagnosed, clinicians should determine asthma endotype (Type2-high or Type2-low) to help choose the best therapy for the patient. Asthma endotype, clinical ...

The case illustrates how these 2 different conditions may share a related mechanism of action. A recent case report details how a teenage participant in a phase 3 pivotal trial for a biologic for ...

The investigational Bruton's tyrosine kinase (BTK) inhibitor rilzabrutinib was associated with numerical decreases in loss of asthma control events for patients with poorly controlled asthma, ...

Please provide your email address to receive an email when new articles are posted on . “Asthma and rheumatoid arthritis (RA) are both prevalent diseases with well-defined immunological bases, with ...

Childhood asthma was associated with difficulties with memory and other cognitive functions, according to an observational cohort study. In a longitudinal analysis, children with earlier onset of ...